PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs
Peter L. Turecek(University of Vienna), Inge A. Ivens(Bayer (United States))
Cited by 707
Related Papers
High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension
|Thrombosis and Haemostasis|2003|254